Details

NameSymbolSector
ORCHID PHARMA LIMITEDORCHPHARMAPharmaceuticals
Open
935
High
938.95
Low
896
Close
911.25
Volume
104768
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Orchid Pharma is  
None
Estimated Stoploss of Orchid Pharma is ₹  
938.95
Orchid Pharma has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Orchid Pharma is  
Unpredictableℹ
. 

Trend

Orchid Pharma is in  
Sideways trendℹ
. 
Price of Orchid Pharma is  
Downℹ
 by  

8.15

%. 
Target
Buy @ 

903.41

Sell @ 

1090.29

Current @ 

911.25

Volume

The trade volumes of Orchid Pharma have become  
Deficientℹ
The volume trend for Orchid Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Orchid Pharma is  

Down

 by  

37.84

% 

Valuation

The current market price of Orchid Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 1687cr and total assets worth ₹ 1687cr, the balance sheet of Orchid Pharma is:  
Balancedℹ
. 
Cashflow
Orchid Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Upℹ
 by  

194.44

%. 

(*Mar 2025)

27.14% i.e. ₹ 19cr earned in operatingℹ
37.14% i.e. ₹ 26cr spent in investingℹ
35.71% i.e. ₹ 25cr earned in financingℹ
0% in otherℹ
Orchid Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 18cr

. It is  
Downℹ
 by  

200

%. 

(*Mar 2024)

20.7% i.e. ₹ 125cr earned in operatingℹ
51.66% i.e. ₹ 312cr spent in investingℹ
27.65% i.e. ₹ 167cr earned in financingℹ
0% in otherℹ
Income
The income of Orchid Pharma is  

₹ 204cr

 and  

Loss

 is :  

₹ 3cr

(*Sep 2025)

Orchid Pharma Losses increased by:  

123.08

% and Income is Up by:  

10.87

% 

(*Sep 2025)

The income of Orchid Pharma is  

₹ 184cr

 and  

Profit

 is :  

₹ 13cr

(*Jun 2025)

Orchid Pharma Profit is down by:  

31.58

% and Income is Down by:  

23.65

% 

(*Jun 2025)

The income of Orchid Pharma is  

₹ 241cr

 and  

Profit

 is :  

₹ 19cr

(*Mar 2025)

Orchid Pharma Profit is down by:  

13.64

% and Income is Up by:  

7.11

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.